# The Use of Botox in Advanced Parkinson's Patients Experiencing Pain

> **NCT02472210** · PHASE4 · UNKNOWN · sponsor: **University Health Network, Toronto** · enrollment: 14 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Botulinum Toxin

## Key facts

- **NCT ID:** NCT02472210
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-07
- **Primary completion:** 2015-07
- **Final completion:** 2015-09
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2015-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02472210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02472210, "The Use of Botox in Advanced Parkinson's Patients Experiencing Pain". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02472210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*